AI Drug Developer
June 22, 2026As of the 25th,BIO International ConventionGrandly held in San Diego, USA. As a leading AI-driven innovative enterprise in drug R&D, MindRank will attend the conference with its AI-powered drug discovery platform and self-developed innovative drug pipeline, engaging in face-to-face exchanges with biopharmaceutical companies, investment institutions, and industry partners from around the world.

At this conference, MindRank will showcase:
The world’s first AI-designed oral small-molecule GLP-1 drug to enter Phase III clinical trials;
A portfolio of novel drug candidates with first-in-class or best-in-class potential, centered on the metabolic pipeline;
Self-developed Industrial-Grade One-Stop AI-Driven New Drug R&D Platform Engine,Covering the Entire Drug R&D Process:PharmKGTMMolecule Pro: A Knowledge Graph-Based Data Mining PlatformTMOne-Stop AI Drug Design Platform, Molecule DanceTMProtein dynamics simulation and structure prediction platform, preclinical prediction platform, and clinical prediction platform.
Exhibition Information
Exhibition Name
BIO International Convention 2026
Exhibition Dates
June 22–25, 2026
Exhibition Venue
San Diego Convention Center, USA
San Diego, USA
Contact Information
Search for “MindRank” via the official BIO Partnering™ system to send us a meeting invitation directly, or schedule an appointment in advance through official channels.
Email Address:bd@mindrank.ai
We look forward to meeting you in sunny San Diego and collaborating together!
About the BIO International Convention

The BIO International Convention, established in 1993 and organized by the Biotechnology Innovation Organization (BIO), has become one of the largest, most specialized, and influential annual biotechnology events worldwide, enjoying a prestigious reputation within the industry. The BIO Convention attracts approximately 20,000 global biotechnology professionals each year, bringing together leading pharmaceutical companies, biotech firms, investors, service providers, and other stakeholders. Through a series of professional forums, partnering sessions, and other activities, it provides a comprehensive platform for information exchange and dissemination, technological collaboration and transactions, and venture capital financing.
About MindRank

MindRank is a global leader in AI-driven drug discovery, dedicated to empowering new drug development through machine learning, reinforcement learning, and first-principles calculations. Leveraging its proprietary, one-stop AI platform that deeply integrates biology, structural biology, chemistry, and medicine, MindRank pushes the boundaries of pharmaceutical technology to ensure more diseases become treatable and more lives are restored to health.
For more information, please visit the website:
www.mindrank.ai
Partnership: bd@mindrank.ai

Others: info@mindrank.ai

Recommended Reading

